EURACTIV - As the European Commission prepares its Biotech Act, Belgium's biotech sector has submitted detailed responses to the Commission's call for evidence, advocating for a bold and comprehensive legislative package. Read more

EU PERSPECTIVES - Danish MEP Stine Bosse (Renew Europe), Vice-Chair of the SANT Committee on Public Health, believes the EU must treat health not only as a social responsibility, but as a matter of investment and security. That means reversing cuts to the EU health budget, tackling antimicrobial resistance (AMR) with coordinated European...

EU PERSPECTIVES - The European Commission will present the core of its proposal for the EU's next seven-year budget on 16 July. Additional building blocks will follow later. Green MEP Tilly Metz warns that the next Multiannual Financial Framework (MFF) risks deprioritising health, both politically and financially. Read more

EU PERSPECTIVES - The European Commission has identified up to €83 million to support the Critical Medicines Act (CMA) during the final two years of the current EU budget cycle. The funding, as Health-Director General Sandra Gallina confirmed, is to come from existing programmes. Read more

EU PERSPECTIVES - Pre-commercial procurement should be used as a strategic tool to accelerate health research and development, and strengthen Europe's competitiveness. EU will push soon for environmentally sustainable, climate-neutral and circular health and care systems. Read more

EU PERSPECTIVES - As the EU prepares its Biotech Act, US stakeholders warn that without systemic reform, Europe may miss its biotech moment. Commissioner Olivér Várhelyi calls for a reimagined EU biotech and pharma ecosystem. Read more

EURACTIV - While Belgium's government endorsed the EU's new pharmaceutical agreement, the country's pharmaceutical industry warns that the text weakens innovation safeguards. Belgium's pharma sector has also criticised the government for deviating from its earlier position. Read more

EU PERSPECTIVES - As trilogue negotiations on the EU's pharmaceutical legislation begin this week, over 70 patient organisations are calling on the bloc's policymakers to preserve their voice in medicines regulation. Read more

EU PERSPECTIVES - Europe has the science, the workforce, and the global footprint to lead in pharmaceutical innovation. However, it still treats the pharmaceutical sector as a budget line, not a strategic asset. Read more

EURACTIV - As Belgium's government pushes ambitious reforms, a donor scandal and professional unrest are exposing deeper tensions in the country's health system. Read more